Revvity (RVTY) is expected to announce a decrease in Q3 earnings and will release its earnings report on Monday. Despite this, the
board declared a dividend. Analysts have given it a consensus rating of
Moderate Buy. It is noted for managing its debt responsibly and has made significant progress on sustainability and workplace culture, as highlighted in its recent Impact Report. The company has introduced
Transcribe AI, which is revolutionising data entry in clinical labs.
Assenagon Asset Management S.A. has sold a significant number of shares while
Squarepoint Ops LLC holds a sizeable investment. Although there are concerns over struggling performance in 2024, some analysts have increased their rating for the company, even raising its price target. Remarkably, those who invested in Revvity five years ago would have seen a 53% gain. Finally, amid these developments, the company has filed a complaint and sought injunctive relief against Cloud Software Group.
Revvity RVTY News Analytics from Thu, 08 Sep 2011 07:00:00 GMT to Fri, 01 Nov 2024 11:25:34 GMT -
Rating - 5
- Innovation 3
- Information 5
- Rumor -3
